---
document_datetime: 2025-11-27 12:53:07
document_pages: 26
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/metalyse-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: metalyse-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 12.4312995
conversion_datetime: 2025-12-18 20:24:06.345166
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Metalyse

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                  |
|----------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|--------------------------------------------------------------------------|
| II/0075/G            | This was an application for a group of variations. A grouped application comprised of 4 Type II Variations, as follows: C.I.4: Update of sections 4.3 and 4.4 of the SmPC | 19/06/2025                          |                                             | SmPC and PL                      | For information, please refer to the Summary of Product Characteristics. |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The

CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| order to update the safety the prevention of bleeding thrombolytic treatment of literature review including outcomes. The Package accordingly. C.I.4: Update of section update the safety information weight < 50 kg based on reanalysis of existing clinical review. The Package Leaflet C.I.4: Update of section the medical recommendations patients based on a dataset of existing clinical data Package Leaflet is updated C.I.4: Update of section revise the medical recommendation most current medical knowledge guidelines. The Package accordingly. In addition, the MAH took the list of local representatives and to introduce minor well as to update the excipient to the latest EU Excipients the PI is being brought   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|           | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                 |            |     |      |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|
| IB/0076   | B.II.z - Quality change - Finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 14/01/2025 | n/a |      |
| II/0074/G | This was an application for a group of variations. B.II.e.5.c - Change in pack size of the finished product - Change in the fill weight/fill volume of sterile multidose (or single-dose, partial use) parenteral medicinal products, including biological/immunological medicinal products B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information B.II.e.1.a.3 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Sterile medicinal products and biological/immunological medicinal products | 24/10/2024 |     | SmPC |

<div style=\"page-break-after: always\"></div>

|           | B.II.b.4.c - Change in the batch size (including batch size ranges) of the finished product - The change requires assessment of the comparability of a biological/immunological medicinal product or a new bioequivalence study B.II.b.3.c - Change in the manufacturing process of the finished or intermediate product - The product is a biological/immunological medicinal product and the change requires an assessment of comparability   |            |            |                        |                                                                        |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------------------------------------------------|
| IB/0072/G | This was an application for a group of variations. B.II.c.3.z - Change in source of an excipient or reagent with TSE risk - Other variation B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer                                                                                                                                        | 04/03/2024 | n/a        |                        |                                                                        |
| IA/0071   | B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier                                                                                                                                                                                                                                                                                                      | 23/02/2024 | n/a        |                        |                                                                        |
| II/0070/G | This was an application for a group of variations. C.I.6.a - Change(s) to therapeutic indication(s) - Addition of a new therapeutic indication or modification of an approved one B.II.e.5.c - Change in pack size of the finished product - Change in the fill weight/fill volume of sterile multidose (or single-dose, partial use) parenteral medicinal products, including                                                                  | 14/12/2023 | 12/01/2024 | SmPC, Labelling and PL | Please refer to Scientific Discussion 'Metalyse-H-C-000306- II-0070-G' |

<div style=\"page-break-after: always\"></div>

|           | biological/immunological medicinal products B.II.e.1.b.2 - Change in immediate packaging of the finished product - Change in type/addition of a new container - Sterile medicinal products and biological/immunological medicinal products B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |     |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| II/0069/G | This was an application for a group of variations. B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of | 21/09/2023 | n/a |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.II.d.1.a - Change in and/or limits of the finished specification limits B.I.b.1.b - Change in and/or limits of an AS, material/intermediate/reagent specification limits B.I.b.1.b - Change in and/or limits of an AS, material/intermediate/reagent specification limits B.I.b.2.e - Change in starting material/reagent/intermediate changes to a test procedure or addition) for the AS material/intermediate B.I.b.2.e - Change in starting material/reagent/intermediate changes to a test procedure or addition) for the AS material/intermediate B.I.b.2.d - Change in starting material/reagent/intermediate change to or replacement biological/immunological/immunochemical method or a method using biological AS B.I.b.2.d - Change in   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

| change to or replacement biological/immunological/immunochemical method or a method using biological AS B.I.b.z - Change in control variation B.I.b.z - Change in control variation B.I.b.2.e - Change in test starting material/reagent/intermediate changes to a test procedure or addition) for the AS material/intermediate B.I.a.2.c - Changes in the the AS - The change refers manufacture of a biological/immunological which may have a significant product and is not related B.I.a.1.j - Change in the starting material/reagent/intermediate Replacement or addition control/testing takes place method at the site is a B.II.b.2.b - Change to importer, arrangements and quality Replacement/addition of control/testing takes place product and any of the biol/immunol method A.5.b - Administrative change and/or address of a manufacturer/importer   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|                    | (excluding manufacturer for batch release)                                                                                                                                                                                                                                                                                                                                                                                                                          |            |            |                                  |                                   |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------|
| PSUSA/2888/ 202208 | Periodic Safety Update EU Single assessment - tenecteplase                                                                                                                                                                                                                                                                                                                                                                                                          | 14/04/2023 | n/a        |                                  | PRAC Recommendation - maintenance |
| IB/0067            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                      | 19/01/2023 | 24/07/2023 | SmPC, Annex II, Labelling and PL |                                   |
| IB/0066/G          | This was an application for a group of variations. B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) B.II.f.1.e - Stability of FP - Change to an approved stability protocol B.II.f.1.e - Stability of FP - Change to an approved | 14/09/2022 | 24/07/2023 | SmPC                             |                                   |
| IAIN/0065          | B.IV.1.b - Change of a measuring or administration device - Deletion of a device                                                                                                                                                                                                                                                                                                                                                                                    | 08/08/2022 | 24/07/2023 | SmPC and PL                      |                                   |
| II/0064/G          | This was an application for a group of variations. B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test                                                                                                                                                                                                                                   | 02/09/2021 | n/a        |                                  |                                   |

<div style=\"page-break-after: always\"></div>

|         | biological AS B.I.b.2.c - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure for a reagent, which does not have a significant effect on the overall quality of the AS                                                                                                                                                                                                                                                                                                                                        |            |            |                 |             |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-------------|
| N/0063  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 13/07/2021 | 06/01/2022 | PL              |             |
| IA/0062 | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                              | 07/01/2021 | n/a        |                 |             |
|         | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place | 07/01/2021 | 06/01/2022 | Annex II and PL | IAIN/0061/G |
| IA/0060 | B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 21/08/2020 | n/a        |                 |             |

<div style=\"page-break-after: always\"></div>

|                    | dossier) - Replacement or addition of a supplier                                                                                                                                                                                                                                                                                                   |            |            |                                  |                                   |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------|
| IB/0059            | B.I.a.z - Change in manufacture of the AS - Other variation                                                                                                                                                                                                                                                                                        | 24/04/2020 | n/a        |                                  |                                   |
| PSUSA/2888/ 201908 | Periodic Safety Update EU Single assessment - tenecteplase                                                                                                                                                                                                                                                                                         | 17/04/2020 | n/a        |                                  | PRAC Recommendation - maintenance |
| II/0057            | B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation                                                                                                                                                                                                                                                                       | 25/10/2018 | n/a        |                                  |                                   |
| N/0056             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                   | 25/07/2018 | 28/09/2018 | PL                               |                                   |
| IB/0055            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                     | 14/10/2017 | 28/09/2018 | SmPC, Annex II, Labelling and PL |                                   |
| IA/0054            | B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer                                                                                                                                                                                       | 17/06/2016 | n/a        |                                  |                                   |
| IB/0053/G          | This was an application for a group of variations. B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size | 17/06/2016 | n/a        |                                  |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0052            | B.I.b.z - Change in control of the AS - Other variation                                                                                                                                                                                                                                                                                               | 03/06/2016   | n/a        |                        |                                                                                                                                                                                                                                                                                                                                            |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0051            | C.I.7.b - Deletion of - a strength                                                                                                                                                                                                                                                                                                                    | 20/10/2015   | 21/10/2016 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                            |
| PSUSA/2888/ 201408 | Periodic Safety Update EU Single assessment - tenecteplase                                                                                                                                                                                                                                                                                            | 10/04/2015   | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                          |
| II/0049            | B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance which may have a significant impact on the medicinal product and is not related to a protocol                                                                                            | 22/01/2015   | n/a        |                        |                                                                                                                                                                                                                                                                                                                                            |
| IB/0048/G          | This was an application for a group of variations. B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method | 27/10/2014   | n/a        |                        |                                                                                                                                                                                                                                                                                                                                            |
| II/0046            | Update of sections 4.2, 4.3, 4.4, 4.6, 5.1 and 5.2 of the SmPC in order to include: a recommendation to administer Metalyse with caution in elderly patients (> 75 years); an amendment of the existing contraindication on concomitant use of Metalyse in patients on oral anticoagulants; a warning regarding                                       | 25/09/2014   | 18/09/2015 | SmPC and PL            | In this variation the MAH proposed the update of the Metalyse product information to include a recommendation to administer Metalyse with caution in elderly patients (> 75 years); an amendment of the existing contraindication on concomitant use of Metalyse in patients on blood thinning drugs; a warning regarding need to transfer |

<div style=\"page-break-after: always\"></div>

|           | transfer to a coronary intervention capable facility for adjunctive PCI and consequent clarification of existing warning on primary PCI; formatting/editorial changes in section \"Fertility, Pregnancy and Lactation\" and \"Clinical Pharmacokinetics\"; and results from the STREAM study. The MAH took also the opportunity to align the Product Information to the QRD template version 9. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data   |            |            | patients to a facility capable of ensuring appropriate treatment and diagnosis if they have received Metalyse as coronary intervention. The MAH included also results from the STREAM study which evaluated the efficacy and safety of a pharmaco-invasive strategy versus a strategy of standard primary percutaneous coronary intervention (PCI) in patients with acute myocardial infarction within 3 hours of onset of symptoms.   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IG/0432   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                                                                                 | 16/04/2014 | n/a        |                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| N/0045    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                | 03/02/2014 | 20/02/2014 |                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| IB/0044/G | This was an application for a group of variations. B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.b - Change in the specification parameters                                                                                             | 13/03/2013 | n/a        |                                                                                                                                                                                                                                                                                                                                                                                                                                        |

<div style=\"page-break-after: always\"></div>

| and/or limits of an AS, material/intermediate/reagent specification limits B.I.b.1.b - Change and/or limits of an AS, material/intermediate/reagent specification limits B.I.b.2.c - Change in starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change in starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change in starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change in starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change in starting material/reagent/intermediate changes to a test procedure does not have a significant   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| B.I.b.2.c - Change starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change in starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change in starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change in starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change in starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change in starting material/reagent/intermediate changes to a test procedure does not have a significant quality of the AS B.I.b.2.c - Change in starting material/reagent/intermediate changes to a test procedure   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| quality of the AS B.III.2.a.2 - Change of non Pharmacopoeial substance Ph. Eur. or with a national Member State - Excipient/AS B.III.2.a.2 - Change of non Pharmacopoeial substance Ph. Eur. or with a national Member State - Excipient/AS B.III.2.a.2 - Change of non Pharmacopoeial substance Ph. Eur. or with a national Member State - Excipient/AS B.III.2.a.2 - Change of non Pharmacopoeial substance Ph. Eur. or with a national Member State - Excipient/AS B.III.2.a.2 - Change of non Pharmacopoeial substance Ph. Eur. or with a national Member State - Excipient/AS B.III.2.a.2 - Change of non Pharmacopoeial substance Ph. Eur. or with a national Member State - Excipient/AS B.III.2.a.2 - Change of non Pharmacopoeial substance Ph. Eur. or with a national Member State - Excipient/AS B.III.2.a.2 - Change of non Pharmacopoeial substance   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| Member State - Excipient/AS starting material B.III.2.a.2 - Change of specification(s) of a former non Pharmacopoeial substance to comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material B.III.2.a.2 - Change of specification(s) of a former non Pharmacopoeial substance to comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material B.III.2.a.2 - Change of specification(s) of a former non Pharmacopoeial substance to comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material B.III.2.a.2 - Change of specification(s) of a former non Pharmacopoeial substance to comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material B.III.2.a.2 - Change of specification(s) of a former non Pharmacopoeial substance to comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material B.III.2.a.2 - Change of specification(s) of a former non Pharmacopoeial substance to comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material B.III.2.a.2 - Change of specification(s) of a former non Pharmacopoeial substance to comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

| B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent Change in   | B.I.b.1.z -   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|

<div style=\"page-break-after: always\"></div>

| material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent B.I.b.1.z - Change in and/or limits of an AS, material/intermediate/reagent   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|         | an AS, starting material/intermediate/reagent - Other variation B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS   |            |            |                        | and/or limits of   |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------|
| IB/0043 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                             | 18/02/2013 | 20/02/2014 | SmPC, Labelling and PL |                    |
| IG/0211 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                             | 05/09/2012 | n/a        |                        |                    |
| IA/0041 | B.III.1.b.3 - Submission of a new or updated Ph. Eur. TSE Certificate of suitability - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                                           | 13/04/2012 | n/a        |                        |                    |
| II/0036 | To revise the module 3 Drug Substance and Drug product sections. The changes include: -Change in analytical procedure for testing for the primary packaging material and the drug product. -Change in specifications and test procedures for active ingredient and finished product. Update of or change(s) to the pharmaceutical                                                                                                                          | 24/06/2010 | 06/07/2010 |                        | documentation      |

<div style=\"page-break-after: always\"></div>

| IB/0039   | IB_12_b_02_Change in spec. of active subst./agent - test parameter   | 08/02/2010   | n/a   | in manuf. of active subst.   |
|-----------|----------------------------------------------------------------------|--------------|-------|------------------------------|
| IB/0038   | IB_12_b_02_Change in spec. of active subst./agent - test parameter   | 08/02/2010   | n/a   | in manuf. of active subst.   |

<div style=\"page-break-after: always\"></div>

| IB/0037   | IB_25_a_01_Change to comply with Ph. - compliance with EU Ph. - active substance                     | 08/02/2010   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-----------|------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0034   | IA_09_Deletion of manufacturing site                                                                 | 05/03/2009   | n/a        | Annex II                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IB/0033   | IB_25_a_01_Change to comply with Ph. - compliance with EU Ph. - active substance                     | 27/01/2009   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IB/0032   | IB_25_a_01_Change to comply with Ph. - compliance with EU Ph. - active substance                     | 27/01/2009   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IA/0031   | IA_12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening of spec. | 11/05/2007   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IA/0030   | IA_37_a_Change in the specification of the finished product - tightening of specification limits     | 11/05/2007   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IA/0029   | IA_16_b_Submission of new TSE certificate relating to active substance - other substances            | 16/02/2007   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| II/0028   | Update of Summary of Product Characteristics, Labelling and Package Leaflet                          | 24/01/2007   | 05/03/2007 | SmPC, Annex II, Labelling and PL | The MAH has updated sections 4.4 and 5.1 of the SPC in order to include information on the outcome and design of the ASSENT-4 PCI study. The outcome of ASSENT-4 PCI was unfavorable with regards to primary endpoint (death, cardiogenic shock or congestive heart failure) for the facilitated (+Tenecteplase) PCI treatment in comparison to standard PCI treatment. The following text was added to Section 4.4: \"Primary Percutaneous Coronary Intervention If primary PCI is scheduled according to the current |

<div style=\"page-break-after: always\"></div>

| relevant treatment guidelines, Metalyse as administered in the ASSENT-4 PCI study (see section 5.1) should not be given.\"  and to Section 5.5:  The ASSENT-4 PCI study was designed to show if in 4000 patients with large myocardial infarctions pre-treatment with full dose tenecteplase and concomitant single bolus of up to 4,000 IU unfractionated heparin administered prior to primary Percutaneous Coronary Intervention (PCI) to be performed within 60 to 180 minutes leads to better outcomes than primary PCI alone. The trial was prematurely terminated with 1667 randomised patients due to a numerically higher mortality in the facilitated PCI group receiving tenecteplase. The occurrence of the primary endpoint, a composite of death or cardiogenic shock or congestive heart failure within 90 days, was significantly higher in the group receiving the exploratory regimen of tenecteplase followed by routine immediate PCI: 18.6% (151/810) compared to 13.4% (110/819) in the PCI only group, p=0.0045. This significant difference between the groups for the primary endpoint at 90 days was already present in-hospital and at 30 days.  Numerically all of the components of the clinical composite endpoint were in favour of the PCI only regimen: death: 6.7% vs. 4.9% p=0.14; cardiogenic shock: 6.3% vs. 4.8% p=0.19; congestive heart failure: 12.0% vs. 9.2% p=0.06 respectively. The secondary endpoints re-infarction and repeat target vessel revascularisation were significantly increased in the   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|         | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                     | 14/12/2005   | 13/02/2006   | SmPC, Annex II, Labelling and PL   | R/0027   |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------------------|----------|
| II/0022 | Quality changes                                                                                                                                                                                                                                                                             | 17/11/2005   | 25/11/2005   |                                    |          |
| II/0023 | Change(s) to the test method(s) and/or specifications for the active substance                                                                                                                                                                                                              | 15/09/2005   | 23/09/2005   |                                    |          |
| IB/0025 | IB_12_b_02_Change in spec. of active subst./agent in manuf. of active subst. - test parameter                                                                                                                                                                                               | 21/09/2005   | n/a          |                                    |          |
| IB/0026 | IB_12_b_02_Change in spec. of active subst./agent in manuf. of active subst. - test parameter                                                                                                                                                                                               | 16/09/2005   | n/a          |                                    |          |
| IA/0024 | IA_12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening of spec.                                                                                                                                                                                        | 14/09/2005   | n/a          |                                    |          |
| IB/0018 | IB_38_b_Change in test procedure of finished product - minor change, biol. active subst./excipient                                                                                                                                                                                          | 19/08/2005   | n/a          |                                    |          |
| IB/0015 | IB_42_a_01_Change in shelf-life of finished product - as packaged for sale                                                                                                                                                                                                                  | 12/01/2005   | n/a          |                                    |          |
| IB/0017 | IA_12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening of spec. IB_13_b_Change in test proc. for active substance - other changes (replacement/addition) IB_12_b_02_Change in spec. of active subst./agent in manuf. of active subst. - test parameter | 21/12/2004   | n/a          |                                    |          |
| IB/0016 | IA_12_a_Change in spec. of active subst./agent used                                                                                                                                                                                                                                         | 21/12/2004   | n/a          |                                    |          |

<div style=\"page-break-after: always\"></div>

|         | in manuf. of active subst. - tightening of spec. IB_13_b_Change in test proc. for active substance - other changes (replacement/addition) IB_12_b_02_Change in spec. of active subst./agent in manuf. of active subst. - test parameter   |            |            |                        |                     |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|---------------------|
| IB/0014 | IA_13_a_Change in test proc. for active substance - minor change IB_12_a_Change in spec. of active subst./agent used subst. - tightening                                                                                                  | 17/12/2004 | n/a        |                        | in manuf. of active |
| IA/0013 | IA_12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening of spec.                                                                                                                                      | 17/11/2004 | n/a        |                        |                     |
| N/0012  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                          | 04/10/2004 | n/a        | PL                     |                     |
| II/0011 | Change(s) to shelf-life or storage conditions                                                                                                                                                                                             | 25/09/2003 | 27/01/2004 | SmPC and PL            |                     |
| II/0009 | Update of Summary of Product Characteristics and Package Leaflet                                                                                                                                                                          | 25/09/2003 | 27/01/2004 | SmPC and PL            |                     |
| II/0007 | Change(s) to container                                                                                                                                                                                                                    | 25/04/2003 | 23/07/2003 | SmPC, Labelling and PL |                     |
| I/0010  | 17_Change in specification of the medicinal product                                                                                                                                                                                       | 02/07/2003 | 07/07/2003 |                        |                     |
| I/0008  | 01_Change in the name of a manufacturer of the medicinal product 11a_Change in the name of a manufacturer of the                                                                                                                          | 21/05/2003 | 25/06/2003 | Annex II and PL        | active substance    |

<div style=\"page-break-after: always\"></div>

| I/0006   | 12_Minor change of manufacturing process of the active substance                                 | 22/05/2003   | 06/06/2003   |                        |
|----------|--------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|
| II/0004  | Update of Summary of Product Characteristics and Package Leaflet                                 | 17/10/2002   | 24/01/2003   | SmPC and PL            |
| N/0005   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 14/10/2002   | 27/11/2002   | PL                     |
| II/0003  | New presentation(s)                                                                              | 30/05/2002   | 18/09/2002   | SmPC, Labelling and PL |
| II/0002  | Quality changes Update of Summary of Product Characteristics and Package Leaflet                 | 13/12/2001   | 02/04/2002   | SmPC and Labelling     |
| II/0001  | Quality changes                                                                                  | 26/07/2001   | 15/10/2001   |                        |